Noni Ellison McKee bought $11k of HEQ
other at John Hancock Diversified Income Fund. 1,070 shares at an average of $10.54, traded Dec 23, 2024, filed Dec 26, 2024.
Score components
- +8RoleOther
- 0Trade size$11k at market
- +10Relative to holdingsHoldings up 91%
- 0Price contextNo price history yet
- 0ClusterNo other insider buying within 14 days
- 0Repeat buyingFirst buy in 90 days
- 0Track recordToo few past buys to judge (0 with prices)
What happened after comparable buys
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0002048097-24-000005, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Dec 23, 2024 | POpen-market purchase common shares of beneficial ownership | +1,070 | $10.54 | $11k | 2,252 | Dec 26, 2024 |
Related signals
Other insiders at John Hancock Diversified Income Fund and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 23Weak | HEQbuy John Hancock Diversified Income Fund | Kenneth J Phelan director | $10k 905 shares | - | |
| 33Weak | HEQbuy John Hancock Diversified Income Fund | Thomas Rowe Wright director | $11k 1,139 shares | - | |
| 16Weak | HEQbuy John Hancock Diversified Income Fund | William K Bacic other | $10k 986 shares | - |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.